Medical Writing 2

Medical Writing NDA Clinical Modules

Writing the clinical documents of an standard new drug application (NDA), requires an understanding of the drug development process, a strong grasp of scientific principles, and the ability to write clearly and effectively.  It also requires a grasp of the type of data included in each module as well as the key purpose each section serves.

Our hands-on course for clinical and regulatory-focused individuals in the pharmaceutical industry will allow you to apply your skills to the clinical documents in an NDA submission. This 8-week course will focus on learning how to interpret and organize clinical data and write standard clinical documents in an NDA submission.  Also covered is an overview of the NDA’s role in the drug approval process and the guidelines and regulations that dictate the content of an NDA. Lead medical writer responsibilities will be covered as well as hands-on exercises for a key essential clinical NDA submission document. Additional insights into the tools of the trade are also integrated into the course material.

 

Who Should Take This Course

This is an excellent program for:

  • A student or scientist interested in a career as a medical or regulatory writer in the pharmaceutical industry who has already completed the MMS University Course in the Fundamentals of Medical Writing.
  • A writer already working in the field that is interested in continued learning opportunities.

At the end of this course, students will have a foundation in the requirements for writing clinical documents in a standard NDA submission. Additionally, the student will gain hands on experience with some of the complex aspects of presenting clinical data.

 

Duration and Prerequisites

A total of 8 weeks is needed for completing the program.

Education and/or Experience
A BS in life sciences field, graduate level education preferred.* Experience in pharma is a plus.

System Requirements

Must have a strong understanding of Word and Microsoft Office.

 

Assessments

Knowledge checks will be performed through a quiz in every session. Evaluation of written reports will be performed through multiple assignments/exercises and will conclude with a final examination. A minimum of 75% is required to pass the final examination.

 

* Degrees or diplomas from educational institutions outside the United States must be equivalent to degrees from U.S. educational institutions.

Course Fee

$1,975 USD

APPLY NOW

Meet Our Instructors

Dr. Amanda Beaster has over 5 years pharmaceutical writing experience and holds the title of Technical Manager of Medical and Regulatory Writing for MMS. Since joining MMS, Dr. Beaster has been a lead writer on several types of clinical documents, such as Clinical Study Reports, (CSRs), Clinical  Study Protocols, (CSPs), Manuscripts and Patient Narratives.

Dr. Ranjana Sundara has nearly 5 years of clinical experience and 3 years of technical writing experience, including experience as a medical writing lead for clinical NDA submission documents.  She has successfully written complex regulatory writing documents, including Clinical Study Protocols and Phase 2 and Phase 3 Clinical Study Reports.

Get Certified

Understanding the difference if various types or certification is important before pursuing any online education program. MMS University provides assessment-based certificates in compliance with ICE 1100 standards.

Scholarships & Internships

Find out if you qualify for scholarship support or an internship opportunity with with MMS.

MMS Holdings Inc.
6880 Commerce Blvd.
Canton, MI 48187, USA

Tel: (734) 245-0310

Fax: (734) 245-0320

info@mmsholdings.com

 

Enter your email address to join our mailing list

JOIN